April 9, 2010
The U.S. Court of Appeals for the Federal Circuit affirmed on April 1 a lower court’s dismissal of a declaratory judgment action against the holder of patents related to a device for treating chronic wounds. The court rejected arguments that lawsuits initiated by the patent holder after the declaratory judgment action was filed created a controversy under the Declaratory Judgment Act. Kinetic Concepts, Inc. holds rights in five patents; Innovative Therapies, Inc., established by several former Kinetic employees, sought a declaration in 2007 that Kinetic’s patents were invalid. Kinetic moved to dismiss the action for lack of jurisdiction under the Declaratory Judgment Act. A district court judge found there was no actual controversy, and dismissed the claim. Innovative appealed, but Judge Pauline Newman rejected Innovative’s arguments that the district court had erred in its finding that certain factors did not establish the existence of a controversy of “sufficient immediacy and reality,” to establish jurisdiction under MedImmune, Inc. v. Genentech, Inc. Kinetic is represented in this matter by Finnegan partner Donald Dunner.
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Press Release
Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination
May 11, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.